Literature DB >> 1682594

Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.

L Herroelen1, J de Keyser, G Ebinger.   

Abstract

2 patients had neurological symptoms and signs, with evidence of central-nervous-system demyelination, 6 weeks after administration of recombinant hepatitis B vaccine. 1 had known multiple sclerosis but the other had no history of neurological disease; both had HLA haplotypes DR2 and B7, which are associated with multiple sclerosis. A causal link between vaccination and demyelination cannot be established from these 2 case-reports, but the time interval would fit a proposed immunological mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682594     DOI: 10.1016/0140-6736(91)92034-y

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

Review 1.  Demyelinating disease and hepatitis B vaccination: is there a link?

Authors:  T Jefferson; H Heijbel
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Recurrent skin peeling following Kawasaki disease.

Authors:  C Michie; V Kinsler; R Tulloh; S Davidson
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

Review 3.  Adverse events after hepatitis B vaccination.

Authors:  P Duclos
Journal:  CMAJ       Date:  1992-10-01       Impact factor: 8.262

4.  Factors influencing the uptake of childhood immunisation in rural areas.

Authors:  Rob Henderson; Ken Oates; Helen MacDonald; W Cairns S Smith; Sivasubramaniam Selvaraj
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

5.  Models cannot predict future outbreaks: A/H1N1 virus, the paradigm.

Authors:  Antoine Nougairède; Rémi N Charrel; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2010-12-14       Impact factor: 8.082

Review 6.  [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]

Authors:  M Löbermann; B Handorn; A Winkelmann; E C Reisinger; H P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

7.  Hepatitis B vaccine and neurotoxicity.

Authors:  M Pirmohamed; P Winstanley
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

8.  Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype.

Authors:  G Kaplanski; F Retornaz; J Durand; J Soubeyrand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

Review 9.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

10.  Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine.

Authors:  F Ronchi; P Cecchi; F Falcioni; A Marsciani; G Minak; G Muratori; P L Tazzari; S Beverini
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.